{"slideshow_credits": null, "snippet": "As an F.D.A. advisory panel revisits the debate around the diabetes drug Avandia, a report by staff scientists has found no fraud in its clinical trial.", "abstract": "Report by Food and Drug Administration scientists concludes that review of disputed clinical trial on safety of controversial diabetes drug Avandia did not uncover serious misconduct or fraud; drug has been found to raise risk of heart attacks.", "section_name": "Business Day", "print_page": "3", "document_type": "article", "byline": {"person": [{"firstname": "Katie", "role": "reported", "lastname": "THOMAS", "rank": 1, "organization": ""}], "original": "By KATIE THOMAS", "contributor": ""}, "web_url": "http://www.nytimes.com/2013/06/04/business/fda-experts-find-no-misconduct-in-avandia-tests.html", "lead_paragraph": "As an F.D.A. advisory panel revisits the debate around the diabetes drug Avandia, a report by staff scientists has found no fraud in its clinical trial.", "headline": {"seo": "F.D.A. Scientists Find No Serious Misconduct in Avandia Tests", "main": "F.D.A. Scientists Find No Serious Misconduct in Avandia Drug Tests", "print_headline": "F.D.A. Scientists Find No Serious Misconduct in Avandia Drug Tests"}, "_id": "51acb83040e9ec65d203afb0", "word_count": "531", "multimedia": [{"height": 126, "url": "images/2013/06/04/business/subAvandia/subAvandia-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2013/06/04/business/subAvandia/subAvandia-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 1050, "url": "images/2013/06/04/business/subAvandia/subAvandia-articleLarge.jpg", "legacy": {"xlarge": "images/2013/06/04/business/subAvandia/subAvandia-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "1050"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2013/06/04/business/subAvandia/subAvandia-thumbStandard.jpg", "legacy": {"thumbnail": "images/2013/06/04/business/subAvandia/subAvandia-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2013-06-04T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "N", "rank": "1"}, {"value": "Avandia (Drug)", "name": "subject", "is_major": "Y", "rank": "2"}, {"value": "Clinical Trials", "name": "subject", "is_major": "N", "rank": "3"}, {"value": "GlaxoSmithKline PLC", "name": "organizations", "is_major": "N", "rank": "4"}, {"value": "Food and Drug Administration", "name": "organizations", "is_major": "N", "rank": "5"}, {"value": "Tests (Medical)", "name": "subject", "is_major": "N", "rank": "6"}, {"value": "Diabetes", "name": "subject", "is_major": "Y", "rank": "7"}], "blog": [], "subsection_name": null, "type_of_material": "News"}